Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohkan Shamsi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Radiology|February 27, 2019
Don't Throw Away RECIST 1.1 Quite YetRichard H Patt, Kohkan Shamsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Onsite image evaluations and independent image blinded reads: close cousins or distant relatives?Kohkan Shamsi, Richard H Patt
Investigative Radiology|October 13, 2006
A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials dataKohkan Shamsi, E Kent Yucel, Paul Chamberlin
European Radiology|June 28, 2006
Vasovist-enhanced MR angiographyMathias Goyen, Kohkan Shamsi, Stefan O Schoenberg
Journal of Magnetic Resonance Imaging : JMRI|March 22, 2005
Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acidJeffrey M Brody, Leah Schafer, Glenn A Tung, et al.
Radiology|September 11, 2004
MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery diseaseChristoph U Herborn, Michaela Schmidt, Oliver Bruder, et al.
Pancreas|April 6, 2026
pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic CancerRobert C G Martin, Eric Scheon, Narayanan Govindarajan, et al.
Radiology|August 29, 2003
Coronary arteries: contrast-enhanced MR imaging with SH L 643A--experience in 12 volunteersChristoph U Herborn, Jörg Barkhausen, Ingo Paetsch, et al.
AJR. American Journal of Roentgenology|December 21, 2007
Safety and efficacy of gadofosveset-enhanced MR angiography for evaluation of pedal arterial disease: multicenter comparative phase 3 studyEnrique Bosch, Karl-Friedrich Kreitner, Mario Fava Peirano, et al.
Radiology|November 1, 2003
MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trialPierre Perreault, Mark A Edelman, Richard A Baum, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Radiology|February 27, 2019
Don't Throw Away RECIST 1.1 Quite YetRichard H Patt, Kohkan Shamsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Onsite image evaluations and independent image blinded reads: close cousins or distant relatives?Kohkan Shamsi, Richard H Patt
Investigative Radiology|October 13, 2006
A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials dataKohkan Shamsi, E Kent Yucel, Paul Chamberlin
European Radiology|June 28, 2006
Vasovist-enhanced MR angiographyMathias Goyen, Kohkan Shamsi, Stefan O Schoenberg
Journal of Magnetic Resonance Imaging : JMRI|March 22, 2005
Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acidJeffrey M Brody, Leah Schafer, Glenn A Tung, et al.
Radiology|September 11, 2004
MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery diseaseChristoph U Herborn, Michaela Schmidt, Oliver Bruder, et al.
Pancreas|April 6, 2026
pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic CancerRobert C G Martin, Eric Scheon, Narayanan Govindarajan, et al.
Radiology|August 29, 2003
Coronary arteries: contrast-enhanced MR imaging with SH L 643A--experience in 12 volunteersChristoph U Herborn, Jörg Barkhausen, Ingo Paetsch, et al.
AJR. American Journal of Roentgenology|December 21, 2007
Safety and efficacy of gadofosveset-enhanced MR angiography for evaluation of pedal arterial disease: multicenter comparative phase 3 studyEnrique Bosch, Karl-Friedrich Kreitner, Mario Fava Peirano, et al.
Radiology|November 1, 2003
MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trialPierre Perreault, Mark A Edelman, Richard A Baum, et al.
Pageof 2